Performance of the US Food and Drug Administration's COVID-19 Disease Severity Categorization for Use in Real-World Data

被引：0

作者：

Perez-Vilar, Silvia ^{[1
]}

Hua, Wei ^{[2
]}

Kwist, Andrew ^{[3
]}

Ma, Yuxin ^{[3
]}

Dong, Diane ^{[4
]}

Zhang, Rongping

Ma, Yong ^{[5
]}

Chavez, Andrea J. ^{[3
]}

Huang, Nina ^{[6
]}

Sheikh, Virginia ^{[7
]}

Chiang, Yiyun ^{[3
]}

Salone, Cedric ^{[4
]}

Pica, Natalie ^{[8
]}

Zhu, Yunfan ^{[3
]}

Pratt, Natasha ^{[1
]}

Nadimpalli, Gita ^{[3
]}

Pershing, Suzann ^{[3
]}

Wernecke, Michael ^{[3
]}

Cunningham, Fran E. ^{[9
]}

Kelman, Jeffrey A. ^{[10
]}

Graham, David J. ^{[1
]}

机构：

[1] US FDA, Silver Spring, MD USA

[2] US FDA, Ctr Drug Evaluat & Res, Off Surveillance & Epidemiol, Silver Spring, MD USA

[3] Acumen LLC, Burlingame, CA USA

[4] Dept Vet Affairs, Washington, DC USA

[5] FDA, Ctr Drug Evaluat & Res, Off Biostatist, Off Translat Sci, Silver Spring, MD USA

[6] VA Hines PBM Medicat Safety, Bethesda, MD USA

[7] US Food & Drug Adm FDA, CDER OND OID Div Anvivirals, Silver Spring, MD USA

[8] FDA, Silver Spring, MD USA

[9] Vet Hlth Adm, Washington, DC USA

[10] Ctr Medicare Medicaid Serv, Washington, DC USA

来源：

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

491

引用

页码：200 / 200

页数：1